Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-07-07
1996-07-02
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 544238, 544295, 544357, 544360, 544393, 564123, A61K 31495, A61K 31505, C07D29515, C07D40104
Patent
active
055322425
ABSTRACT:
##STR1## This invention concerns compounds of formula (I) where A is an alkylene chain of 2 to 5 carbon atoms optionally substituted by one or more lower alkyl groups, R represents hydrogen or one or two same or different lower alkyl groups, R.sup.1 is a monocyclic aryl or heteroaryl radical, R.sup.2 is a mono or bicyclic aryl radical and R.sup.3 is cycloalkyl. The compounds of the invention are useful as antidepressant, antianxiety, or hypotensive agents; or for regulating the sleep/wake cycle, feeding behavior and/or sexual function; and for treating cognition disorders.
REFERENCES:
patent: 3037982 (1962-06-01), Fancher et al.
patent: 4988814 (1991-01-01), Abou-Gharbia et al.
patent: 5010078 (1991-04-01), Abou-Gharbia et al.
patent: 5340812 (1994-08-01), Cliffe
Cliffe et al, Chemical Abstracts, vol. 118, No. 169115 (1993) (Abstract for EP 512755, Nov. 11, 1992).
Bernhardt Emily
John Wyeth & Brother Limited
Seifert Arthur G.
LandOfFree
Piperazine derivatives as 5-HT receptors antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine derivatives as 5-HT receptors antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives as 5-HT receptors antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506604